Innate Pharma S.A. (IPHA) Q4 2024 Earnings Call Transcript

2025-03-27 16:49:38 ET

Innate Pharma S.A. (IPHA)

Q4 2024 Earnings Conference Call

March 27, 2025, 09:00 AM ET

Company Participants

Henry Wheeler - VP, IR and Communications

Jonathan Dickinson - CEO

Yannis Morel - COO

Sonia Quaratino - CMO

Frederic Lombard - CFO

Conference Call Participants

Daina Graybosch - Leerink Partners

Swayampakula Ramakanth - H.C. Wainwright

Presentation

Operator

Hello, and welcome to the Innate Pharma Full Year 2024 Financial Results and Business Update. All lines have been placed on mute to prevent any background noise. After the speakers’ remarks, there will be a question-and-answer session. [Operator Instructions] I would now like to turn the conference over to Henry Wheeler, Vice President, Investor Relations and Communications. You may begin.

Henry Wheeler

Thank you. Good morning, good afternoon, and welcome, everyone. This morning, Innate issued a press release for our full year 2024 business update and financial results. We look forward to highlighting the progress made during the year to date as well as addressing future goals and milestones. The press release and today’s presentation are both available on the IR section of our website.

On Slide 2, before we start, I would like to remind you that we will be making forward looking statements regarding the financial outlook in addition to the regulatory and product plan development. These statements are subject to risks and uncertainties that may cause actual results to differ from those forecasted....

Read the full article on Seeking Alpha

For further details see: